Trials / Unknown
UnknownNCT04098510
Concentration of MitoQ in Human Skeletal Muscle
Concentration of Mitoquinone Mesylate in Skeletal Muscle After a Single Oral Dose of MitoQ
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 10 (estimated)
- Sponsor
- University of Copenhagen · Academic / Other
- Sex
- Male
- Age
- 18 Years – 40 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to determine mitoquinone mesylate concentration levels in skeletal muscle samples obtained after intake of an acute oral dose of MitoQ.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | MitoQ | Subjects ingest 8x20 mg MitoQ capsules |
Timeline
- Start date
- 2019-09-08
- Primary completion
- 2020-09-30
- Completion
- 2020-09-30
- First posted
- 2019-09-23
- Last updated
- 2019-09-23
Locations
1 site across 1 country: Denmark
Source: ClinicalTrials.gov record NCT04098510. Inclusion in this directory is not an endorsement.